Cyramza is a prescription medication used to treat various types of cancers, including stomach cancer, lung cancer, and colorectal cancer. The medication is marketed under the trade name of Cyramza by Elif Pharma. It is an intravenous injection that contains 100 mg of the active ingredient ramucirumab in 10 ml solution.
Ramucirumab is classified as a monoclonal antibody. It works by binding to a protein called vascular endothelial growth factor (VEGF), which is involved in the growth of blood vessels that supply tumors. By binding to VEGF, ramucirumab helps to prevent the growth and spread of cancer cells.
Cyramza injection should be administered by a healthcare professional, in a hospital or clinic setting. The dosage and frequency of administration will depend on the type and stage of cancer being treated. The medication may be administered once every two weeks or once every three weeks, depending on the treatment regimen.
Like all medications, Cyramza can cause some side effects. The most common ones include fatigue, high blood pressure, and nausea. Some patients may also experience decreased appetite, vomiting, diarrhea, and abdominal pain. It is important to notify the doctor if any of these side effects persist or become severe.
In some cases, Cyramza can cause more serious side effects, such as bleeding, blood clots, heart problems, and immune reactions. Patients should seek immediate medical attention if they experience any symptoms of these serious side effects, such as sudden weakness or numbness, chest pain, shortness of breath, or fever.
Before receiving Cyramza injection, patients should inform their doctor of any pre-existing medical conditions, including bleeding disorders, high blood pressure, or heart disease. Patients should also inform their doctor of any medications they are currently taking, including prescription drugs, over-the-counter medications, herbal remedies, and supplements.
In conclusion, Cyramza is an effective medication used in the treatment of various types of cancers. The medication works by binding to VEGF and helping to prevent the growth and spread of cancer cells. Patients should receive Cyramza injection as directed by their physician and should notify their doctor if any side effects occur or become severe.
Reviews
There are no reviews yet.